PPAR activation may limit inflammation and atherosclerosis

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1411, 2003-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PPAR-&ggr; Agonists as Regulators of Microglial Activation and Brain Inflammation

By  

Current Pharmaceutical Design, Vol. 12, Iss. 1, 2006-01 ,pp. : 93-109

Bentham Science Publishers

Access to resources Recommend Favorite

Gliclazide, Inflammation and Atherosclerosis

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 7, Iss. 3, 2008-09 ,pp. : 224-230

Bentham Science Publishers

Access to resources Recommend Favorite

HDL and Inflammation in Atherosclerosis

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 4, Iss. 1, 2004-03 ,pp. : 51-57

Bentham Science Publishers

Access to resources Recommend Favorite

Insulin Resistance, Inflammation and Atherosclerosis

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 7, Iss. 3, 2008-09 ,pp. : 172-186

Bentham Science Publishers

Access to resources Recommend Favorite

Pathophysiology of Atherosclerosis: The Role of Inflammation

By  

Current Pharmaceutical Design, Vol. 17, Iss. 37, 2011-12 ,pp. : 4089-4110

Bentham Science Publishers

Access to resources Recommend Favorite